# Alliott Cole

> Alliott Cole is a funding round investor at Octopus Ventures backing Health Care and Medical. See 14 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Octopus Ventures](https://shizune.co/investors/profile/octopus-ventures)
- Location: New York, United States
- Total investments: 14
- Last investment: Jan 2022
- Lead investor: 36%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/alliottcole
- X (Twitter): http://twitter.com/alliott
- Website: http://www.octopusventures.com

Alliott Cole is a funding round investor at Octopus Ventures in New York focused on Health Care and Medical. Alliott Cole serves as Chief Executive Officer at Octopus Ventures. He joined the Octopus Ventures team at the start of 2008 as the team began investing their first fund.He currently also serves as a Board Member at Secret Escapes, Cazoo, Swoon Editions and Big Health. He focuses on internet-enabled services, enterprise software, and consumerinnovation. Alliott Chairs the Investment Committee at Octopus Ventures and sits on the Board of the Octopus Group Executive Committee. Alliott has also spent two years working in the US when he established Octopus Ventures’ office in New York.The key investments he has been involved in at Octopus include Antidote.me (a digital healthcare company); Conversocial (a B2B customer service software); the food e-commerce business Graze (acquired by Unilever), the ecommerce platform Rangespan (acquired by Google), the machine learning business Magic Pony (acquired by Twitter), Permutive (an edge computing company); Sofar Sounds (a global music company); the pet food company Tails.com (acquired by Nestle), and the property portal website Zoopla (acquired by SilverLake).Before arriving at Octopus, he previously worked as a lawyer at Ashurst, where he spent time working for IBM, Sporting Bet, UC Rusal, and NM Rothschild. Alliott has also held positions on the Board of the British Business Angel Association. He holds a Masters in Classics from Oxford University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 21% |
| Medical | 2 | 14% |
| Biotechnology | 2 | 14% |
| Health Diagnostics | 2 | 14% |
| Retail | 1 | 7% |

30 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 4 | 29% |
| Series A | 3 | 21% |
| Series B | 3 | 21% |
| Series C | 2 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 5 | 36% |
| United States | 2 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Big Health | Big Health is a digital therapeutics company that operates a digital healthcare portal to offer fully-automated and highly personalized digital therapeutics and behavioral programs for mental health issues. Its portal offers an online personalized medicine-care and prepares a sleep improvement program in consultation with medical professionals thatenable individuals to overcome their sleep-related disorders in an efficient manner. | $75M | Series C | Jan 19, 2022 |  |
| Big Health | Big Health is a digital therapeutics company that operates a digital healthcare portal to offer fully-automated and highly personalized digital therapeutics and behavioral programs for mental health issues. Its portal offers an online personalized medicine-care and prepares a sleep improvement program in consultation with medical professionals thatenable individuals to overcome their sleep-related disorders in an efficient manner. | $39M | Series B | Jun 18, 2020 |  |
| Antidote.me | Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster.Antidote was launched as TrialReach in 2010 and rebranded toAntidote in 2016. The company is based in the US and the UK. |  |  | Sep 07, 2017 |  |
| iovox | Our mission at iovox is to make data from all phone calls as useful, valuable, and actionable. Trusted by leading brands and global customers in more than 30 countries, iovox delivers on its mission via call analytics, productivity and collaboration solutions. |  | Series A | Oct 27, 2016 |  |
| Big Health | Big Health is a digital therapeutics company that operates a digital healthcare portal to offer fully-automated and highly personalized digital therapeutics and behavioral programs for mental health issues. Its portal offers an online personalized medicine-care and prepares a sleep improvement program in consultation with medical professionals thatenable individuals to overcome their sleep-related disorders in an efficient manner. | $12M | Series B | Jul 27, 2016 |  |
| Antidote.me | Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster.Antidote was launched as TrialReach in 2010 and rebranded toAntidote in 2016. The company is based in the US and the UK. |  |  | Apr 14, 2016 |  |
| Conversocial | Conversocial is a Customer Experience Platform for Messaging Channels.Your customers have moved to messaging — your brand should too. Conversocial simplifies how brands communicate with their customers by combining human agents and bots in a single platform. The result; frictionless customer experiences throughout the customer lifecycle thatenhance customer loyalty and drive revenue — at scale. Forward-thinking brands such as Google, Sephora, British Airways, and Facebook trust Conversocial to help them embrace messaging as an efficient and scalable customer experience channel. Conversocial has offices in New York City, London and San Francisco with a global team of people passionate about helping brands build and scale meaningful relationships with their customers. | $11M |  | Oct 19, 2015 |  |
| Secret Escapes | At Secret Escapes, they negotiate exclusive rates for luxury hand-picked hotels and holidays in the UK and abroad, at up to 60% off the price you'd pay by booking anywhere else. How have they done it? Well, even the most luxurious hotels out there don't like having empty rooms...For access to their members-only rates, all you have to dois sign up to Secret Escapes with your email address and nothing else. It doesn't cost a penny, and never will.In return, they will give you access to rates for hotels and holidays you'll struggle to find anywhere else, and if you do they will match their price - that's a guarantee. | $60M | Series C | Jul 27, 2015 |  |
| Michelson Diagnostics | Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more. | $2.7M | Series B | Feb 16, 2015 |  |
| Antidote.me | Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster.Antidote was launched as TrialReach in 2010 and rebranded toAntidote in 2016. The company is based in the US and the UK. | $13.5M | Series B | Feb 05, 2015 |  |

10 of 14 investments shown.

## Co-investors
- [Atlas Venture](https://shizune.co/investors/profile/atlas-venture) — VC Fund, 3 deals together
- [Molten Ventures](https://shizune.co/investors/profile/draper-esprit) — VC Fund, 3 deals together
- [Kaiser Permanente Ventures](https://shizune.co/investors/profile/kaiser-permanente-ventures) — VC Fund, 3 deals together
- [Gilde Healthcare](https://shizune.co/investors/profile/gilde-healthcare-partners) — VC Fund, 2 deals together
- [LocalGlobe](https://shizune.co/investors/profile/localglobe) — VC Fund, 2 deals together
- [Morningside](https://shizune.co/investors/profile/morningside-group) — VC Fund, 2 deals together

## About Octopus Ventures

VC Fund · London, United Kingdom

Octopus Ventures is a venture capital firm that offers support to companies at various stages of their journey, from idea conception to IPO. They allocate over £200 million annually to invest in sectors such as health, fintech, deep tech, consumer, and B2B software, with a focus on making a positive impact. Their experienced team assists portfoliocompanies in scaling rapidly. Octopus Ventures' investment philosophy extends beyond monetary support, involving time, energy, and focus to work closely with founders for success. Notable companies they have backed include ManyPets, Cazoo, Depop, Elvie, and WaveOptics. Their operations span London and New York, with a network of partners in the U.S. and Asia.

5 contacts available at Octopus Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Alliott Cole | CEO | https://shizune.co/investors/profile/alliott-cole |
| Jo Oliver | Director | https://shizune.co/investors/profile/jo-oliver |
| Luke Hakes | Partner | https://shizune.co/investors/profile/luke-hakes |
| Uthish Ranjan | Partner | https://shizune.co/investors/profile/uthish-ranjan |
| Zoe Chambers | Early Stage Investor | https://shizune.co/investors/profile/zoe-chambers |

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Alliott Cole invest in?

Alliott Cole invests primarily in Health Care, Medical and Biotechnology startups, most often at Funding Round and Series A stage. Most of the 14 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Alliott Cole last invest?

The most recent investment recorded for Alliott Cole closed in Jan 2022. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co